Literature DB >> 7777548

Human immunodeficiency virus 1 reservoir in CD4+ T cells is restricted to certain V beta subsets.

D Dobrescu1, S Kabak, K Mehta, C H Suh, A Asch, P U Cameron, A S Hodtsev, D N Posnett.   

Abstract

The human immunodeficiency virus 1 (HIV-1) replicates more efficiently in T-cell lines expressing T-cell receptors derived from certain V beta genes, V beta 12 in particular, suggesting the effects of a superantigen. The targeted V beta 12 subset was not deleted in HIV-1-infected patients. It was therefore possible that it might represent an in vivo viral reservoir. Viral load was assessed by quantitative PCR with gag primers and with an infectivity assay to measure competent virus. It was shown that the tiny V beta 12 subset (1-2% of T cells) often has a higher viral load than other V beta subsets in infected patients. Selective HIV-1 replication in V beta 12 cells was also observed 6-8 days after in vitro infection of peripheral blood lymphocytes from normal, HIV-1 negative donors. Viral replication in targeted V beta subsets may serve to promote a biologically relevant viral reservoir.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7777548      PMCID: PMC41736          DOI: 10.1073/pnas.92.12.5563

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

Review 1.  Molecular interactions among herpesviruses and human immunodeficiency viruses.

Authors:  J Laurence
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

2.  Superantigen implicated in dependence of HIV-1 replication in T cells on TCR V beta expression.

Authors:  J Laurence; A S Hodtsev; D N Posnett
Journal:  Nature       Date:  1992-07-16       Impact factor: 49.962

3.  Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals.

Authors:  S M Schnittman; H C Lane; J Greenhouse; J S Justement; M Baseler; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

4.  Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction.

Authors:  O Bagasra; S P Hauptman; H W Lischner; M Sachs; R J Pomerantz
Journal:  N Engl J Med       Date:  1992-05-21       Impact factor: 91.245

5.  Dissociation of gp120 from HIV-1 virions induced by soluble CD4.

Authors:  J P Moore; J A McKeating; R A Weiss; Q J Sattentau
Journal:  Science       Date:  1990-11-23       Impact factor: 47.728

6.  Transgenic mouse mammary tumor virus superantigen expression prevents viral infection.

Authors:  T V Golovkina; A Chervonsky; J P Dudley; S R Ross
Journal:  Cell       Date:  1992-05-15       Impact factor: 41.582

7.  The effects of chronic infection with a superantigen-producing virus.

Authors:  L Ignatowicz; J Kappler; P Marrack
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

8.  Characterization of human T cells reactive with the Mycoplasma arthritidis-derived superantigen (MAM): generation of a monoclonal antibody against V beta 17, the T cell receptor gene product expressed by a large fraction of MAM-reactive human T cells.

Authors:  S M Friedman; M K Crow; J R Tumang; M Tumang; Y Q Xu; A S Hodtsev; B C Cole; D N Posnett
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

9.  Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection.

Authors:  M I Bukrinsky; T L Stanwick; M P Dempsey; M Stevenson
Journal:  Science       Date:  1991-10-18       Impact factor: 63.714

10.  Preferential V beta gene usage and lack of junctional sequence conservation among human T cell receptors specific for a tetanus toxin-derived peptide: evidence for a dominant role of a germline-encoded V region in antigen/major histocompatibility complex recognition.

Authors:  B Boitel; M Ermonval; P Panina-Bordignon; R A Mariuzza; A Lanzavecchia; O Acuto
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Virus-encoded superantigens.

Authors:  B T Huber; P N Hsu; N Sutkowski
Journal:  Microbiol Rev       Date:  1996-09

Review 2.  Study of the T cell receptor repertoire in viral immunodeficiency disease.

Authors:  C Ciurli; R P Sékaly; H Soudeyns
Journal:  Springer Semin Immunopathol       Date:  1996

Review 3.  Superantigens related to B cell hyperplasia.

Authors:  N M Ponzio; V K Tsiagbe; G J Thorbecke
Journal:  Springer Semin Immunopathol       Date:  1996

4.  Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope.

Authors:  J Richardson; A Moraillon; S Baud; A M Cuisinier; P Sonigo; G Pancino
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  T cell receptor usage in patients with non-progressing HIV infection.

Authors:  M D Bodman-Smith; I Williams; R Johnstone; A Boylston; P M Lydyard; A Zumla
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

6.  Early increase of CD4+ CD45RA+ and CD4+ CD95- cells with conserved repertoire induced by anti-retroviral therapy in HIV-infected patients.

Authors:  G Silvestri; C Munoz-Calleja; P Bagnarelli; G Piedimonte; M Clementi; M Montroni
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

7.  Productive infection of double-negative T cells with HIV in vivo.

Authors:  G Marodon; D Warren; M C Filomio; D N Posnett
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

8.  TCR binding differs for a bacterial superantigen (SEE) and a viral superantigen (Mtv-9).

Authors:  L Liao; A Marinescu; A Molano; C Ciurli; R P Sekaly; J D Fraser; A Popowicz; D N Posnett
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.